<DOC>
	<DOCNO>NCT02966912</DOCNO>
	<brief_summary>The objective study investigate whether nutritional supplementation magnesium improve cardiovascular structure function participant obesity - long-term goal prevent clinical heart failure . Specifically , randomize open-label pilot study , ass whether dietary Magnesium ( Mg ) supplementation ( versus supplementation ) 24 week obese patient improve leave ventricular ( LV ) mass .</brief_summary>
	<brief_title>Magnesium Supplementation Primary Prevention Heart Failure Obesity</brief_title>
	<detailed_description>The investigator propose 24-week therapeutic trial involve 40 participant obesity Providence VA Medical Center without clinical heart failure . 20 participant treat 400 mg Magnesium Oxide twice daily , 20 participant receive treatment . The trial test hypothesis oral Mg supplementation improve : LV structure ( LV mass , steatosis , ECV ) , LV function ( systolic diastolic ) , vascular health ( systolic blood pressure aortic pulse wave velocity ) visceral adiposity .</detailed_description>
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Magnesium Oxide</mesh_term>
	<criteria>Body mass index great 30 kg/m2 1 . History hospitalization heart failure ( systolic diastolic ) ; 2 . Unstable angina prior myocardial infarction ; 3 . LV ejection fraction &lt; 50 % imaging study ; 4 . Valvular heart disease ( stenosis insufficiency ) great moderate degree ; 5 . Renal dysfunction , serum creatinine &gt; 2.5 mg/dL estimate creatinine clearance &lt; 30 mL/min/1.73 m2 ( 30 ) , 6 . Pregnant woman actively breastfeed woman 7 . History drug supplementation within last 6 month 50 miliequivalents per day supplemental magnesium contain</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>